{"altmetric_id":1871579,"counts":{"readers":{"mendeley":23,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":3,"unique_users":["1409409501","639176255","205367482920841"],"posts_count":3},"blogs":{"unique_users_count":1,"unique_users":[55622],"posts_count":1},"googleplus":{"unique_users_count":2,"unique_users":["Lymphoma Hub","John Lucas"],"posts_count":2},"news":{"unique_users_count":12,"unique_users":["medicalxpress","newswise","the_medical_news","drugs_com","health24","medical_news_today","the_asco_post","science_daily","medpage_today","eurekalert","health_canal","medlineplus"],"posts_count":12},"total":{"posts_count":71},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1},"twitter":{"unique_users_count":45,"unique_users":["JSweetenhamMD","ymori117","FrancescoTurtu1","lymphomahub","medinternaRyP","gessieannelopes","medicineupdate","CRWLibrary","billykensan","meals2heal","BiblioHemato","SWOG","ckesserwan","Senology","LungCaNetwork","drkomanduri","shinsuke_amano","timfenske","VetDiagInvest","mlema","OncoNerd","koguus","SysnetCardiff","Lymphomation","constusalud","Transplant_Doc","hematologiaH12O","DrMvandenBrink","GIMBE","tomheston","celltherapynews","tvtjftan","sodohem_rd","granitehead","Lymphoma_Doc","tumikatama","kxhtr237","JebSource","geydson","mtmdphd","NatRevClinOncol","concaff","Maynaia","EJG_deuce","JACV1968"],"posts_count":52}},"selected_quotes":["#SWOGonc 9704: Early stem cell trnsplnt in aggressive non-Hodgkin #lymphoma: OS improved only in pts at highest risk","Autologous transplant for aggressive lymphoma, either upfront or at relapse, is associated with similar survival","Consolidaci\u00f3n con autotrasplante en NHL Agresivo de riesgo intermedio\/alto y alto aumenta PFS, pero no el OS -","Autologous Transplantation in Aggressive Lymphoma"],"citation":{"abstract":"The efficacy of autologous stem-cell transplantation during the first remission in patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate risk or high risk on the International Prognostic Index remains controversial and is untested in the rituximab era.","abstract_source":"pubmed","altmetric_jid":"4f6fa50e3cf058f6100031c4","authors":["Patrick J. Stiff","Joseph M. Unger","James R. Cook","Louis S. Constine","Stephen Couban","Douglas A. Stewart","Thomas C. Shea","Pierluigi Porcu","Jane N. Winter","Brad S. Kahl","Thomas P. Miller","Raymond R. Tubbs","Deborah Marcellus","Jonathan W. Friedberg","Kevin P. Barton","Glenn M. Mills","Michael LeBlanc","Lisa M. Rimsza","Stephen J. Forman","Richard I. Fisher","Stiff PJ","Unger JM","Cook JR","Constine LS","Couban S","Stewart DA","Shea TC","Porcu P","Winter JN","Kahl BS","Miller TP","Tubbs RR","Marcellus D","Friedberg JW","Barton KP","Mills GM","LeBlanc M","Rimsza LM","Forman SJ","Fisher RI","Stiff, Patrick J."],"doi":"10.1056\/nejmoa1301077","endpage":"1690","first_seen_on":"2013-10-31T01:41:48+00:00","funders":["nci"],"issns":["0028-4793","1533-4406"],"issue":"18","journal":"New England Journal of Medicine","last_mentioned_on":1461169035,"links":["http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=TOC&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077#.UnIye0UyBcE.linkedin","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=TOC&utm_content=bufferd69ab&utm_source=buffer&utm_medium=twitter&utm_campaign=Buffer&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home#.UnJl3DSAT78.twitter&","http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1301077","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077#.UnKdhyTv5vY.twitter","http:\/\/dx.doi.org\/10.1056\/NEJMoa1301077","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home#.UnLBPr4rjvs.twitter&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=TOC#.UnMnL5NIBnA.twitter&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?af=R&rss=currentIssue&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home#.UnOhPYKzJYQ.twitter&","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24171516?dopt=Abstract","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home#.UnOpxw8RKFM.twitter&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077#.UnRdpw2h0UE.twitter","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077#.UnUwJ6cyWJw.linkedin","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077#.UnU1yuvDNc4.facebook","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?rss=mostEmailed&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home#.UnaCMUGPMNA.twitter&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?elq=9a6739ed906b476ca2bb9212172b4e85&elqCampaignId=6#.UniQtZuLcy0.twitter&","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=oncology-hematology&utm_content=buffer2aa7d&utm_source=buffer&utm_medium=twitter&utm_campaign=Buffer&","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24171516","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077#article","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?utm_source=hootsuite&utm_campaign=hootsuite&"],"pmid":"24171516","pubdate":"2013-10-31T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1681","subjects":["medicine"],"title":"Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma","type":"article","volume":"369","mendeley_url":"http:\/\/www.mendeley.com\/research\/autologous-transplantation-consolidation-aggressive-nonhodgkins-lymphoma-3"},"altmetric_score":{"score":117.158,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":117.158},"context_for_score":{"all":{"total_number_of_other_articles":8059538,"mean":6.8397725663364,"rank":64651,"this_scored_higher_than_pct":99,"this_scored_higher_than":7994890,"rank_type":"exact","sample_size":8059538,"percentile":99},"similar_age_3m":{"total_number_of_other_articles":145817,"mean":7.1026777034072,"rank":1295,"this_scored_higher_than_pct":99,"this_scored_higher_than":144522,"rank_type":"exact","sample_size":145817,"percentile":99},"this_journal":{"total_number_of_other_articles":19833,"mean":47.514551028641,"rank":1882,"this_scored_higher_than_pct":90,"this_scored_higher_than":17950,"rank_type":"exact","sample_size":19833,"percentile":90},"similar_age_this_journal_3m":{"total_number_of_other_articles":322,"mean":84.785190031153,"rank":69,"this_scored_higher_than_pct":78,"this_scored_higher_than":253,"rank_type":"exact","sample_size":322,"percentile":78}}},"demographics":{"poster_types":{"member_of_the_public":33,"researcher":2,"practitioner":8,"science_communicator":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":8,"Members of the public":33,"Scientists":2,"Science communicators (journalists, bloggers, editors)":2}},"mendeley":{"by_status":{"Professor > Associate Professor":3,"Student  > Doctoral Student":2,"Researcher":1,"Student  > Ph. D. Student":5,"Student  > Postgraduate":3,"Other":3,"Student  > Master":1,"Student  > Bachelor":1,"Lecturer":1,"Lecturer > Senior Lecturer":1,"Professor":2},"by_discipline":{"Medicine and Dentistry":15,"Social Sciences":1,"Physics and Astronomy":1,"Psychology":1,"Agricultural and Biological Sciences":1,"Nursing and Health Professions":1,"Mathematics":1,"Unspecified":2}}},"geo":{"twitter":{"JP":5,"US":9,"GB":4,"BR":2,"CO":2,"FR":1,"PA":1,"ES":1,"IT":1,"BA":1,"DO":1,"IE":1,"CL":1},"mendeley":{"SE":1,"US":1}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/718158852","license":"public","citation_ids":[1871579],"posted_on":"2013-11-18T00:00:00+00:00","f1000_classes":["controversial","good_for_teaching"],"f1000_score":"1"}],"twitter":[{"url":"http:\/\/twitter.com\/JSweetenhamMD\/status\/395917232712060929","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T14:16:38+00:00","author":{"name":"John Sweetenham, M.D","url":"http:\/\/www.huntsmancancer.org","image":"https:\/\/pbs.twimg.com\/profile_images\/3699772333\/4a621bd6f9997a3825735059c3e38994_normal.jpeg","description":"Senior Director of Clinical Affairs and Executive Medical Director at @HuntsmanCancer Institute","id_on_source":"JSweetenhamMD","tweeter_id":"1451834838","geo":{"lt":null,"ln":null},"followers":543},"tweet_id":"395917232712060929"},{"url":"http:\/\/twitter.com\/ymori117\/status\/396127232113913856","license":"public","citation_ids":[1871579],"posted_on":"2013-11-01T04:11:06+00:00","author":{"name":"\u68ee\u3000\u52c7\u4e00","url":"http:\/\/twilog.org\/ymori117","image":"https:\/\/pbs.twimg.com\/profile_images\/848199682329255936\/8L7dBR04_normal.jpg","description":"\u9577\u91ce\u770c\u3067\u8840\u6db2\u5185\u79d1\u533b\u3092\u3057\u3066\u3044\u307e\u3059","id_on_source":"ymori117","tweeter_id":"128218698","geo":{"lt":36.65139,"ln":138.18111,"country":"JP"},"followers":3004},"tweet_id":"396127232113913856"},{"url":"http:\/\/twitter.com\/FrancescoTurtu1\/status\/396255529577619456","license":"public","citation_ids":[1871579],"posted_on":"2013-11-01T12:40:54+00:00","author":{"name":"Francesco Turturro","url":"http:\/\/faculty.mdanderson.org\/Francesco_Turturro\/Default.asp?SNID=1484660469","image":"https:\/\/pbs.twimg.com\/profile_images\/763530448618217472\/8el8ozjZ_normal.jpg","description":"Lymphoma specialist expressing his own opinions","id_on_source":"FrancescoTurtu1","tweeter_id":"1191609930","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":968},"tweet_id":"396255529577619456"},{"url":"http:\/\/twitter.com\/lymphomahub\/status\/396257186504249345","license":"public","rt":["FrancescoTurtu1"],"citation_ids":[1871579],"posted_on":"2013-11-01T12:47:30+00:00","author":{"name":"Lymphoma Hub","url":"http:\/\/www.lymphomahub.com","image":"https:\/\/pbs.twimg.com\/profile_images\/816644675025207296\/mwybWyru_normal.jpg","description":"The LH is an online resource dedicated to sharing lymphoma\/CLL latest medical information  within the community hematologists, oncologists and hem-oncologists","id_on_source":"lymphomahub","tweeter_id":"1582593798","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":1895},"tweet_id":"396257186504249345"},{"url":"http:\/\/twitter.com\/medinternaRyP\/status\/396457747262103552","license":"public","citation_ids":[1871579],"posted_on":"2013-11-02T02:04:27+00:00","author":{"name":"medinternaRyP","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000503932927\/d0d4c8a147b8dc3ccc8c951d5ad0717e_normal.jpeg","description":"Twitter Oficial del Postgrado de Medicina Interna UDO BOLIVAR","id_on_source":"medinternaRyP","tweeter_id":"1902117415","geo":{"lt":null,"ln":null},"followers":149},"tweet_id":"396457747262103552"},{"url":"http:\/\/twitter.com\/gessieannelopes\/status\/396014969587646465","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T20:45:01+00:00","author":{"name":"Gessie Anne Lopes MD","url":"http:\/\/lattes.cnpq.br\/5740579079906873","image":"https:\/\/pbs.twimg.com\/profile_images\/2142260793\/41386_1780801541_1390_n_normal.jpg","description":"M\u00e9dica Internista, Oncologista e Hematologista pela PUC\/RS. Bacharelado em Filosofia UFRGS. Titular Especialista da SBC,  ABHH e SBTMO. Embaixadora MSF-BRAZIL.","id_on_source":"gessieannelopes","tweeter_id":"52304814","geo":{"lt":-30.03306,"ln":-51.23,"country":"BR"},"followers":742},"tweet_id":"396014969587646465"},{"url":"http:\/\/twitter.com\/medicineupdate\/status\/396256521039794176","license":"datasift","citation_ids":[1871579],"posted_on":"2013-11-01T12:44:51+00:00","author":{"name":"Tom","url":"http:\/\/j.gs\/1K3w","image":"https:\/\/pbs.twimg.com\/profile_images\/3388626222\/3c70af58befec0257424ebde88c5f261_normal.png","description":"The top 5 internal medicine journals","id_on_source":"medicineupdate","tweeter_id":"174988635","geo":{"lt":null,"ln":null},"followers":3334},"tweet_id":"396256521039794176"},{"url":"http:\/\/twitter.com\/CRWLibrary\/status\/395844633739005953","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T09:28:09+00:00","author":{"name":"Cancer Library VCC","url":"http:\/\/www.wales.nhs.uk\/velindrelibrary","image":"https:\/\/pbs.twimg.com\/profile_images\/478464349476884480\/YlBsicot_normal.jpeg","description":"The only cancer specialist library service in Wales.  Supporting NHS and academic staff, students and health professionals throughout the Principality.","id_on_source":"CRWLibrary","tweeter_id":"1288296943","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":650},"tweet_id":"395844633739005953"},{"url":"http:\/\/twitter.com\/billykensan\/status\/396790541372768258","license":"public","citation_ids":[1871579],"posted_on":"2013-11-03T00:06:51+00:00","author":{"name":"Masahiro K","image":"http:\/\/pbs.twimg.com\/profile_images\/3715404181\/24e5b1b41681a48f9515f687c55c79aa_normal.jpeg","description":"twitter\u4e0a\u3067\u306f\u307e\u3058\u3081\u306a\u533b\u5b66\u751f\u3067\u3059\u3002\u533b\u7642\u30cb\u30e5\u30fc\u30b9\u3092\u4e2d\u5fc3\u306b\u6295\u7a3f\u3057\u3066\u3044\u307e\u3059\u3002","id_on_source":"billykensan","tweeter_id":"1460773057","geo":{"lt":"34.7145739098393","ln":"135.256300034047","country":"JP"},"followers":11},"tweet_id":"396790541372768258"},{"url":"http:\/\/twitter.com\/meals2heal\/status\/398133780197945344","license":"public","citation_ids":[1871579],"posted_on":"2013-11-06T17:04:24+00:00","author":{"name":"Savor Health","url":"http:\/\/www.savorhealth.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/859932629986160641\/tt16PU5l_normal.jpg","description":"Patient-specific, evidence-based personalized nutrition for the cancer patient and their caregivers.","id_on_source":"meals2heal","tweeter_id":"328469335","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1507},"tweet_id":"398133780197945344"},{"url":"http:\/\/twitter.com\/BiblioHemato\/status\/403658093097390080","license":"public","citation_ids":[1871579],"posted_on":"2013-11-21T22:56:03+00:00","author":{"name":"BiblioHemato","image":"http:\/\/pbs.twimg.com\/profile_images\/3100234440\/4261afae9646aa1050ba8593b7873af4_normal.jpeg","id_on_source":"BiblioHemato","tweeter_id":"1080418076","followers":4},"tweet_id":"403658093097390080"},{"url":"http:\/\/twitter.com\/lymphomahub\/status\/405698838339780608","license":"datasift","citation_ids":[1871579],"posted_on":"2013-11-27T14:05:15+00:00","author":{"name":"Lymphoma Hub","url":"http:\/\/www.lymphomahub.com","image":"https:\/\/pbs.twimg.com\/profile_images\/816644675025207296\/mwybWyru_normal.jpg","description":"The LH is an online resource dedicated to sharing lymphoma\/CLL latest medical information  within the community hematologists, oncologists and hem-oncologists","id_on_source":"lymphomahub","tweeter_id":"1582593798","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":1895},"tweet_id":"405698838339780608"},{"url":"http:\/\/twitter.com\/SWOG\/status\/434681029266120704","license":"public","citation_ids":[1871579],"posted_on":"2014-02-15T13:30:08+00:00","author":{"name":"SWOG Cancer Research","url":"http:\/\/swog.org","image":"https:\/\/pbs.twimg.com\/profile_images\/1744097720\/SWOG_282c-on-square-no-tag_normal.png","description":"SWOG designs and conducts clinical trials to better treat and prevent cancer.\nFounded in 1956, a proud member of the NCI's National Clinical Trials Network.","id_on_source":"SWOG","tweeter_id":"459482914","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":3494},"tweet_id":"434681029266120704"},{"url":"http:\/\/twitter.com\/ckesserwan\/status\/434693007401447425","license":"public","rt":["SWOG"],"citation_ids":[1871579],"posted_on":"2014-02-15T14:17:43+00:00","author":{"name":"Chimene Kesserwan","image":"https:\/\/pbs.twimg.com\/profile_images\/782340546429726721\/51xUooTs_normal.jpg","description":"Opinions are mine","id_on_source":"ckesserwan","tweeter_id":"2252597929","geo":{"lt":35.14953,"ln":-90.04898,"country":"US"},"followers":156},"tweet_id":"434693007401447425"},{"url":"http:\/\/twitter.com\/Senology\/status\/395895264646422529","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T12:49:21+00:00","author":{"name":"Senology","url":"http:\/\/www.senology.org","image":"https:\/\/pbs.twimg.com\/profile_images\/1301293396\/logo_style_normal.JPG","description":"Senology.org is the official web site of the International Senologic and Oncologic Scientific Community (ISOSC) - breast diseases and cancer diagnosis and care","id_on_source":"Senology","tweeter_id":"203469783","geo":{"lt":null,"ln":null},"followers":1871},"tweet_id":"395895264646422529"},{"url":"http:\/\/twitter.com\/LungCaNetwork\/status\/395917544932249600","license":"public","rt":["JSweetenhamMD"],"citation_ids":[1871579],"posted_on":"2013-10-31T14:17:53+00:00","author":{"name":"CRAB Clinical Trials","url":"http:\/\/www.crabctc.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/550375924865064961\/9iGmcgEA_normal.png","description":"CRAB CTC aims to provide an international network to rapidly translate novel agents into new treatments for lung cancer.","id_on_source":"LungCaNetwork","tweeter_id":"361490128","geo":{"lt":null,"ln":null},"followers":454},"tweet_id":"395917544932249600"},{"url":"http:\/\/twitter.com\/drkomanduri\/status\/395978376172666880","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T18:19:36+00:00","author":{"name":"Krishna Komanduri","url":"https:\/\/www.linkedin.com\/in\/kkomanduri","image":"https:\/\/pbs.twimg.com\/profile_images\/672613124235730945\/teAgt_NY_normal.jpg","description":"Director, Adult Stem Cell Transplant Program, UM Sylvester Cancer, ASBMT President, father of 4 (triplets+1). Personal Account #bmtsm #tcellrx Opinions mine","id_on_source":"drkomanduri","tweeter_id":"1081903728","geo":{"lt":25.77427,"ln":-80.19366,"country":"US"},"followers":3191},"tweet_id":"395978376172666880"},{"url":"http:\/\/twitter.com\/shinsuke_amano\/status\/396031160414789632","license":"public","rt":["NEJM"],"citation_ids":[1871579],"posted_on":"2013-10-31T21:49:21+00:00","author":{"name":"\u5929\u91ce\u3000\u614e\u4ecb","image":"https:\/\/pbs.twimg.com\/profile_images\/828020556083531776\/n8HTIEf5_normal.jpg","description":"2000\u5e74\u306b27\u6b73\u3067\u30ea\u30f3\u30d1\u816b\u3092\u767a\u75c7\u3001\u5316\u5b66\u7642\u6cd5\u3001\u653e\u5c04\u7dda\u7642\u6cd5\u3001\u9020\u8840\u5e79\u7d30\u80de\u79fb\u690d\u3092\u7d4c\u9a13\u3002\u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u30b0\u30eb\u30fc\u30d7\u30fb\u30cd\u30af\u30b5\u30b9\u30fb\u30b8\u30e3\u30d1\u30f3\u3001\u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u5168\u56fd\u304c\u3093\u60a3\u8005\u56e3\u4f53\u9023\u5408\u4f1a\u7406\u4e8b\u9577\u306a\u3069\u3001\u304c\u3093\u60a3\u8005\u652f\u63f4\u306b\u95a2\u308f\u3063\u3066\u3044\u307e\u3059\u3002\u500b\u4eba\u7684\u898b\u89e3\u3092\u30c4\u30a4\u30fc\u30c8\u3002Lymphoma Survivor, Group Nexus Japan","id_on_source":"shinsuke_amano","tweeter_id":"192852622","geo":{"lt":35.28361,"ln":139.66722,"country":"JP"},"followers":2243},"tweet_id":"396031160414789632"},{"url":"http:\/\/twitter.com\/timfenske\/status\/396445332239687680","license":"public","citation_ids":[1871579],"posted_on":"2013-11-02T01:15:07+00:00","author":{"name":"Tim Fenske","url":"http:\/\/www.mcw.edu\/Hemonc\/faculty\/TimothyFenske.htm","image":"https:\/\/pbs.twimg.com\/profile_images\/771499184356597760\/9KxTNJAO_normal.jpg","description":"Lymphoma, Malignant Hematology, Drug Development, Blood and Marrow Transplantation, and other medical news & views.","id_on_source":"timfenske","tweeter_id":"1036403696","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":1576},"tweet_id":"396445332239687680"},{"url":"http:\/\/twitter.com\/VetDiagInvest\/status\/396683939177181184","license":"public","citation_ids":[1871579],"posted_on":"2013-11-02T17:03:15+00:00","author":{"name":"Vet Diag Invest","url":"http:\/\/t.co\/P0hsKsYndU","image":"http:\/\/a0.twimg.com\/profile_images\/1490182221\/final_normal.jpg","description":"Drs David Bruyette, DACVIM and Jennifer Garcia provide veterinary IM and endocrinology consultation.","id_on_source":"VetDiagInvest","tweeter_id":"35279135","followers":24},"tweet_id":"396683939177181184"},{"url":"http:\/\/twitter.com\/mlema\/status\/401374026683015168","license":"datasift","citation_ids":[1871579],"posted_on":"2013-11-15T15:39:59+00:00","author":{"name":"Mauricio Lema","url":"http:\/\/www.mauriciolema.com","image":"https:\/\/pbs.twimg.com\/profile_images\/515954645\/TwitterMLM02_normal.jpg","description":"Onc\u00f3logo cl\u00ednico \/ Hemat\u00f3logo - vive, si es que as\u00ed puede llamarse - m\u00e1s bien trabaja -, en Medell\u00edn","id_on_source":"mlema","tweeter_id":"21593054","geo":{"lt":4,"ln":-72,"country":"CO"},"followers":181},"tweet_id":"401374026683015168"},{"url":"http:\/\/twitter.com\/OncoNerd\/status\/401374585695657984","license":"public","citation_ids":[1871579],"posted_on":"2013-11-15T15:42:13+00:00","author":{"name":"MLMOncoMeet","url":"http:\/\/mauriciolema.webhost4life.com\/CES201402\/","image":"https:\/\/pbs.twimg.com\/profile_images\/762295394898509825\/Ly6ea2q2_normal.jpg","description":"Nacido en Medell\u00edn, 1964. M\u00e9dico de la UPB, Medell\u00edn, 1989. Medicina interna U de Miami, 1995. Hem-Onc, U de Miami, 1998, Cl\u00ednica SOMA y Astorga (2004-...)","id_on_source":"OncoNerd","tweeter_id":"468592790","geo":{"lt":6.25184,"ln":-75.56359,"country":"CO"},"followers":670},"tweet_id":"401374585695657984"},{"url":"http:\/\/twitter.com\/koguus\/status\/395735278792351744","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T02:13:37+00:00","author":{"name":"koguus","image":"https:\/\/pbs.twimg.com\/profile_images\/686449195977342976\/_Hxcj0dc_normal.jpg","description":"hematologist, classic music, wine\/beer\/sake.","id_on_source":"koguus","tweeter_id":"16183027","geo":{"lt":35.02107,"ln":135.75385,"country":"JP"},"followers":346},"tweet_id":"395735278792351744"},{"url":"http:\/\/twitter.com\/SysnetCardiff\/status\/395850397996568576","license":"public","rt":["CRWLibrary"],"citation_ids":[1871579],"posted_on":"2013-10-31T09:51:04+00:00","author":{"name":"SUREteamCardiff","url":"http:\/\/www.cardiff.ac.uk\/insrv\/libraries\/sure","image":"https:\/\/pbs.twimg.com\/profile_images\/611821830744211456\/6dS2eV0Z_normal.jpg","description":"A team comprised of experienced information specialists and systematic reviewers. Active in conducting systematic reviews and teaching systematic review skills.","id_on_source":"SysnetCardiff","tweeter_id":"474829992","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":466},"tweet_id":"395850397996568576"},{"url":"http:\/\/twitter.com\/lymphomahub\/status\/396276036985688064","license":"public","rt":["FrancescoTurtu1"],"citation_ids":[1871579],"posted_on":"2013-11-01T14:02:24+00:00","author":{"name":"Lymphoma Hub","url":"http:\/\/www.lymphomahub.com","image":"https:\/\/pbs.twimg.com\/profile_images\/816644675025207296\/mwybWyru_normal.jpg","description":"The LH is an online resource dedicated to sharing lymphoma\/CLL latest medical information  within the community hematologists, oncologists and hem-oncologists","id_on_source":"lymphomahub","tweeter_id":"1582593798","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":1895},"tweet_id":"396276036985688064"},{"url":"http:\/\/twitter.com\/Lymphomation\/status\/396345606404579328","license":"public","citation_ids":[1871579],"posted_on":"2013-11-01T18:38:50+00:00","author":{"name":"Lymphomation.org","url":"http:\/\/www.lymphomation.org","image":"https:\/\/pbs.twimg.com\/profile_images\/441512265\/Logo-FB_normal.jpg","description":"http:\/\/Lymphomation.org\/ PAL - partnering with scientists to make progress against lymphoma.  Focus on the ROUTINE and INFORMED consideration of clinical trials","id_on_source":"Lymphomation","tweeter_id":"61825247","geo":{"lt":49.1,"ln":1.96667,"country":"FR"},"followers":2752},"tweet_id":"396345606404579328"},{"url":"http:\/\/twitter.com\/constusalud\/status\/396703356603092992","license":"public","citation_ids":[1871579],"posted_on":"2013-11-02T18:20:25+00:00","author":{"name":"Construyendo tusalud","url":"http:\/\/www.facebook.com\/construyendotusalud","image":"http:\/\/pbs.twimg.com\/profile_images\/1841564746\/elix_normal.jpg","description":"somo una cuenta orientada en la difusi\u00f3n del conocimiento en temas de salud sin fines de lucro respetando las normas de derecho de autor.","id_on_source":"constusalud","tweeter_id":"489686479","geo":{"lt":"8.3096067","ln":"-81.3066246","country":"PA"},"followers":82},"tweet_id":"396703356603092992"},{"url":"https:\/\/twitter.com\/Transplant_Doc\/status\/397164262163881984","license":"public","rt":["drkomanduri"],"citation_ids":[1871579],"posted_on":"2013-11-04T00:51:53+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3419},"tweet_id":"397164262163881984"},{"url":"https:\/\/twitter.com\/hematologiaH12O\/status\/397161103446142976","license":"public","citation_ids":[1871579],"posted_on":"2013-11-04T00:39:20+00:00","author":{"name":"Hematologia H12O","url":"http:\/\/t.co\/I9cd5PskZD","image":"http:\/\/a0.twimg.com\/profile_images\/3785568048\/c1a53477b19ec4806a48597272f3bf39_normal.jpeg","description":"Servicio de Hematolog\u00eda Hospital Universitario 12 de Octubre","id_on_source":"hematologiaH12O","tweeter_id":"1502505781","geo":{"lt":40.4203,"ln":-3.705774,"country":"ES"},"followers":25},"tweet_id":"397161103446142976"},{"url":"https:\/\/twitter.com\/hematologiaH12O\/status\/397158791428714496","license":"public","citation_ids":[1871579],"posted_on":"2013-11-04T00:30:09+00:00","author":{"name":"Hematologia H12O","url":"http:\/\/t.co\/I9cd5PskZD","image":"http:\/\/a0.twimg.com\/profile_images\/3785568048\/c1a53477b19ec4806a48597272f3bf39_normal.jpeg","description":"Servicio de Hematolog\u00eda Hospital Universitario 12 de Octubre","id_on_source":"hematologiaH12O","tweeter_id":"1502505781","geo":{"lt":40.4203,"ln":-3.705774,"country":"ES"},"followers":25},"tweet_id":"397158791428714496"},{"url":"http:\/\/twitter.com\/DrMvandenBrink\/status\/397612295993323520","license":"public","citation_ids":[1871579],"posted_on":"2013-11-05T06:32:13+00:00","author":{"name":"Marcel van den Brink","image":"https:\/\/pbs.twimg.com\/profile_images\/3380100954\/70e6d478a7eb705e9921bf5d039e88c5_normal.jpeg","description":"Head of the Division of Hematologic Oncology at MSKCC. Tweets and opinions are my own. http:\/\/www.mskcc.org\/research\/lab\/marcel-van-den-brink","id_on_source":"DrMvandenBrink","tweeter_id":"1267928143","geo":{"lt":null,"ln":null},"followers":2898},"tweet_id":"397612295993323520"},{"url":"http:\/\/twitter.com\/GIMBE\/status\/398844348676472832","license":"public","citation_ids":[1871579],"posted_on":"2013-11-08T16:07:57+00:00","author":{"name":"GIMBE","url":"http:\/\/www.gimbe.org\/conferenza2017-report","image":"https:\/\/pbs.twimg.com\/profile_images\/3401302047\/1caa828d38ce491598c75c979ccc49d1_normal.jpeg","description":"Online il report della Conferenza #GIMBE2017","id_on_source":"GIMBE","tweeter_id":"98855762","geo":{"lt":42.83333,"ln":12.83333,"country":"IT"},"followers":2317},"tweet_id":"398844348676472832"},{"url":"http:\/\/twitter.com\/tomheston\/status\/399178774647812096","license":"public","citation_ids":[1871579],"posted_on":"2013-11-09T14:16:50+00:00","author":{"name":"Tom Heston","url":"http:\/\/tomheston.com","image":"https:\/\/pbs.twimg.com\/profile_images\/452650157050302464\/-kGG7sgd_normal.png","description":"I help people make wise health decisions. Theese are my medical newsfeed tweets. Follow @tomhestonmd for my personal tweets.","id_on_source":"tomheston","tweeter_id":"21013461","geo":{"lt":44.25,"ln":17.83333,"country":"BA"},"followers":83235},"tweet_id":"399178774647812096"},{"url":"http:\/\/twitter.com\/celltherapynews\/status\/399266578199748608","license":"public","citation_ids":[1871579],"posted_on":"2013-11-09T20:05:44+00:00","author":{"name":"Cell Therapy News","url":"http:\/\/www.celltherapynews.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/748289281672642560\/ULgWUrkm_normal.jpg","description":"The online resource for cell and gene therapy research. Part of the http:\/\/connexoncreative.com\/ family.\nJoin us on Facebook: http:\/\/ow.ly\/4mUNF3","id_on_source":"celltherapynews","tweeter_id":"25326286","geo":{"lt":null,"ln":null},"followers":5743},"tweet_id":"399266578199748608"},{"url":"http:\/\/twitter.com\/meals2heal\/status\/395908035006459904","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T13:40:05+00:00","author":{"name":"Savor Health","url":"http:\/\/www.savorhealth.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/859932629986160641\/tt16PU5l_normal.jpg","description":"Patient-specific, evidence-based personalized nutrition for the cancer patient and their caregivers.","id_on_source":"meals2heal","tweeter_id":"328469335","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1507},"tweet_id":"395908035006459904"},{"url":"http:\/\/twitter.com\/tvtjftan\/status\/395920803264356353","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T14:30:50+00:00","author":{"name":"Tran-Der Tan","image":"https:\/\/pbs.twimg.com\/profile_images\/1412320013\/195324_100000744419130_5160983_q_normal.jpg","description":"Hemato-oncologist and Stem cell transplanter, loves cello and bike","id_on_source":"tvtjftan","tweeter_id":"213592839","followers":20},"tweet_id":"395920803264356353"},{"url":"http:\/\/twitter.com\/sodohem_rd\/status\/396381198336798720","license":"public","citation_ids":[1871579],"posted_on":"2013-11-01T21:00:16+00:00","author":{"name":"SODOHEM","url":"http:\/\/www.sodohem.com.do","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000258703756\/690a395f581162e9b4eb0d3c1865a17b_normal.jpeg","description":"Entidad de car\u00e1cter civil, sin fines de lucro, la cual representa a la totalidad de los especialistas en Hematolog\u00eda.","id_on_source":"sodohem_rd","tweeter_id":"1654628312","geo":{"lt":"19.094175","ln":"-70.3012705","country":"DO"},"followers":57},"tweet_id":"396381198336798720"},{"url":"http:\/\/twitter.com\/granitehead\/status\/396829572354015232","license":"public","citation_ids":[1871579],"posted_on":"2013-11-03T02:41:57+00:00","author":{"name":"brett johnson","url":"http:\/\/www.linkedin.com\/in\/brettrjohnson","image":"https:\/\/pbs.twimg.com\/profile_images\/666244312095694848\/csTWrnn5_normal.jpg","description":"technology and the social dynamic. repository for primary references etc. (tweets are my own and not sponsored) #datasharing #precisionmedicine #HITsm","id_on_source":"granitehead","tweeter_id":"19118873","geo":{"lt":null,"ln":null},"followers":797},"tweet_id":"396829572354015232"},{"url":"http:\/\/twitter.com\/FrancescoTurtu1\/status\/398060539802177538","license":"public","citation_ids":[1871579],"posted_on":"2013-11-06T12:13:22+00:00","author":{"name":"Francesco Turturro","url":"http:\/\/faculty.mdanderson.org\/Francesco_Turturro\/Default.asp?SNID=1484660469","image":"https:\/\/pbs.twimg.com\/profile_images\/763530448618217472\/8el8ozjZ_normal.jpg","description":"Lymphoma specialist expressing his own opinions","id_on_source":"FrancescoTurtu1","tweeter_id":"1191609930","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":968},"tweet_id":"398060539802177538"},{"url":"http:\/\/twitter.com\/Lymphoma_Doc\/status\/395727128735412224","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T01:41:14+00:00","author":{"name":"Jason Westin, MD","url":"http:\/\/faculty.mdanderson.org\/Jason_Westin\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/910134436230025216\/KEOAxbnf_normal.jpg","description":"Lymphoma Specialist at MD Anderson Cancer Center, dreamer and doer, averse to status quo. Opinions are mine.","id_on_source":"Lymphoma_Doc","tweeter_id":"1080058020","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":3351},"tweet_id":"395727128735412224"},{"url":"http:\/\/twitter.com\/tumikatama\/status\/396130014422245376","license":"public","rt":["ymori117"],"citation_ids":[1871579],"posted_on":"2013-11-01T04:22:09+00:00","author":{"name":"MeGaMeGa(\u30ab\u30e9\u30c0\u64e6\u308a\u5207\u308c\u5bf8\u524d)","image":"https:\/\/pbs.twimg.com\/profile_images\/512649047711043584\/wAzHpzLj_normal.jpeg","description":"\u3044\u3088\u3044\u308849\u6b73\u3068\u5927\u53f0\u304c\u76ee\u306e\u524d\u3068\u306a\u3063\u305f\u8840\u6db2\u5185\u79d1\u5c02\u9580\u533b\u306e\u7aef\u304f\u308c\u3067\u3059\u3002\u816b\u760d\u5185\u79d1\u533b\u3078\u306e\u9053\u534a\u3070\u3067\u632f\u308a\u51fa\u3057\u306b\u623b\u308a\u3001\u5927\u5b66\u6559\u54e1\u751f\u6d3b\u3092\u7d4c\u3066\u3001\u81e8\u5e8a\u73fe\u5834\u5fa9\u5e30\u3057\u307e\u3057\u305f\u3002\u304c\u3001\u65e2\u306b\u75b2\u5f0a\u3061\u3046\u3002\u3067\u3082\u697d\u3057\u3002Galaxy s7edge\/\u30b9\u30de\u30db\/BABYMETAL\/\u795e\u30d0\u30f3\u30c9\/\u3067\u3093\u3071\u7d44.inc\/Xmas eileen\/\u8840\u6db2\/\u51dd\u56fa\/\u816b\u760d\/\u7de9\u548c\/\u5b50\u80b2\u3066\/","id_on_source":"tumikatama","tweeter_id":"109802492","geo":{"lt":33.60639,"ln":130.41806,"country":"JP"},"followers":1457},"tweet_id":"396130014422245376"},{"url":"http:\/\/twitter.com\/kxhtr237\/status\/396231653560840193","license":"public","rt":["ymori117"],"citation_ids":[1871579],"posted_on":"2013-11-01T11:06:02+00:00","author":{"name":"taoka megumi","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000584266583\/3e58eedf2ca7541ff50aba10f651b234_normal.jpeg","description":"23\u6b73\u306e\u30b7\u30f3\u30b0\u30eb\u30de\u30b6\u30fc\u2661\u5a18\u306f\u4e8c\u6b73\u3067\u3059(*\u00b4\u2200\uff40*)\u9577\u91ce\u770c\u306b\u4f4f\u3093\u30675\u5e74\u76ee\u2661\u4ed5\u4e8b\u306f10.15\u304b\u3089\u4f50\u4e45\u7dcf\u5408\u75c5\u9662\u3067\u533b\u7642\u79d8\u66f8\u3092\u3057\u307e\u3059\u30fc\u26614\u5e74\u3076\u308a\u306e\u4ed5\u4e8b\u5fa9\u5e30\u3067\u3059(\u00b4\u0414\uff40\u03b9)\u4ee5\u524d\u306f\u30db\u30c6\u30eb\u3067\u50cd\u3044\u3066\u307e\u3057\u305f(\u00b4-\u03b5-\uff40;)","id_on_source":"kxhtr237","tweeter_id":"1954265335","geo":{"_id":"\u4f50\u4e45\u5e02\u5ca9\u6751\u7530"},"followers":9},"tweet_id":"396231653560840193"},{"url":"http:\/\/twitter.com\/FrancescoTurtu1\/status\/396265529586884608","license":"public","citation_ids":[1871579],"posted_on":"2013-11-01T13:20:39+00:00","author":{"name":"Francesco Turturro","url":"http:\/\/faculty.mdanderson.org\/Francesco_Turturro\/Default.asp?SNID=1484660469","image":"https:\/\/pbs.twimg.com\/profile_images\/763530448618217472\/8el8ozjZ_normal.jpg","description":"Lymphoma specialist expressing his own opinions","id_on_source":"FrancescoTurtu1","tweeter_id":"1191609930","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":968},"tweet_id":"396265529586884608"},{"url":"http:\/\/twitter.com\/JebSource\/status\/396905280241696768","license":"datasift","citation_ids":[1871579],"posted_on":"2013-11-03T07:42:47+00:00","author":{"name":"JebSource","image":"https:\/\/pbs.twimg.com\/profile_images\/1464424915\/image_normal.jpg","description":"News of Our Amazing World \u261e society, science, math, nature, and health. Perfect suppliment for people who love to learn with or without school.","id_on_source":"JebSource","tweeter_id":"14790164","geo":{"lt":34.05223,"ln":-118.24368,"country":"US"},"followers":304},"tweet_id":"396905280241696768"},{"url":"http:\/\/twitter.com\/geydson\/status\/397046953223024640","license":"public","citation_ids":[1871579],"posted_on":"2013-11-03T17:05:45+00:00","author":{"name":"GSCruz","image":"https:\/\/pbs.twimg.com\/profile_images\/827107988708155393\/Iit2EQoz_normal.jpg","id_on_source":"geydson","tweeter_id":"69392667","geo":{"lt":-12.97111,"ln":-38.51083,"country":"BR"},"followers":105},"tweet_id":"397046953223024640"},{"url":"http:\/\/twitter.com\/Transplant_Doc\/status\/399589582540259328","license":"public","citation_ids":[1871579],"posted_on":"2013-11-10T17:29:15+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3419},"tweet_id":"399589582540259328"},{"url":"http:\/\/twitter.com\/mtmdphd\/status\/400731981710782464","license":"public","rt":["Transplant_Doc"],"citation_ids":[1871579],"posted_on":"2013-11-13T21:08:44+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"400731981710782464"},{"url":"http:\/\/twitter.com\/NatRevClinOncol\/status\/401345213269946369","license":"public","citation_ids":[1871579],"posted_on":"2013-11-15T13:45:30+00:00","author":{"name":"NatureRevClinOncol","url":"http:\/\/www.nature.com\/nrclinonc\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1587954262\/nrclinonc_Twitter_logo_normal.jpg","description":"The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.","id_on_source":"NatRevClinOncol","tweeter_id":"347276297","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":10546},"tweet_id":"401345213269946369"},{"url":"http:\/\/twitter.com\/concaff\/status\/401345505424596992","license":"public","rt":["NatRevClinOncol"],"citation_ids":[1871579],"posted_on":"2013-11-15T13:46:39+00:00","author":{"name":"Conor Caffrey","url":"http:\/\/www.conorcaffrey.wordpress.com","image":"http:\/\/pbs.twimg.com\/profile_images\/1238222983\/namib3a_normal.jpg","description":"Writer on Science and Medicine. Content Curator. Tweets on medical research, digital health, genes, brains,  pain, diabetes, etc.","id_on_source":"concaff","tweeter_id":"21090777","geo":{"lt":"52.865196","ln":"-7.9794599","country":"IE"},"followers":2008},"tweet_id":"401345505424596992"},{"url":"http:\/\/twitter.com\/Maynaia\/status\/401347513325993984","license":"public","rt":["NatRevClinOncol"],"citation_ids":[1871579],"posted_on":"2013-11-15T13:54:38+00:00","author":{"name":"Ximena Araya","image":"http:\/\/pbs.twimg.com\/profile_images\/3615069247\/7bd035ebf4dc705e591ae68bfee23ba3_normal.jpeg","description":"libertad de informaci\u00f3n, un derecho fundamental\u2026interesada en la ciencia, la tecnolog\u00eda y la discapacidad no importa su naturaleza","id_on_source":"Maynaia","tweeter_id":"276732990","geo":{"lt":"-31.7613365","ln":"-71.3187697","country":"CL"},"followers":345},"tweet_id":"401347513325993984"},{"url":"http:\/\/twitter.com\/EJG_deuce\/status\/402238758827089920","license":"public","citation_ids":[1871579],"posted_on":"2013-11-18T00:56:07+00:00","author":{"name":"Edward Gorak","url":"http:\/\/www.linkedin.com\/in\/egorak","image":"https:\/\/pbs.twimg.com\/profile_images\/597197363166507009\/FUEEeXrZ_normal.jpg","description":"Blood cancer blood disorder physician, teamwork, stem cell transplants, advocate, research, trust, fitness, philanthropy, healthy living, Our fight matters!","id_on_source":"EJG_deuce","tweeter_id":"2182154194","geo":{"lt":null,"ln":null},"followers":428},"tweet_id":"402238758827089920"},{"url":"http:\/\/twitter.com\/JACV1968\/statuses\/722821442820116480","license":"gnip","citation_ids":[1871579],"posted_on":"2016-04-20T16:17:15+00:00","author":{"name":"J A Ca Vi","image":"https:\/\/pbs.twimg.com\/profile_images\/659229216211267584\/aaHCuxjE_normal.jpg","id_on_source":"JACV1968","tweeter_id":"200723236","geo":{"lt":null,"ln":null},"followers":971},"tweet_id":"722821442820116480"}],"facebook":[{"title":"Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma \u2014 NEJM","url":"https:\/\/www.facebook.com\/1409409501\/posts\/10202557963576197","license":"public","citation_ids":[1871579],"posted_on":"2013-11-02T17:27:38+00:00","summary":"A great review and very relevant to the incredible work being done by Dr Chretin and our oncology department with our veterinary bone marrow transplant patients.","author":{"name":"David Bruyette","url":"https:\/\/www.facebook.com\/1409409501","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/1409409501\/picture","id_on_source":"1409409501"}},{"title":"Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma \u2014 NEJM","url":"https:\/\/www.facebook.com\/639176255\/posts\/10151646886136256","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T19:56:20+00:00","summary":"Hani \"de facto\" imm\u00fcnolog gibi hissediyorum ya kendimi, \"Rituximab era\" denince sanki Rituximab'\u0131 kendim ke\u015ffetmi\u015fim gibi seviniyorum. Her neyse, agresif lenfomalarda konsolidasyon tedavisi olarak otolog naklin genel sa\u011fkal\u0131ma pek bir faydas\u0131 bulunmam\u0131\u015f. \"","author":{"name":"Esen Fiercetongue Oktay","url":"https:\/\/www.facebook.com\/639176255","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/639176255\/picture","id_on_source":"639176255"}},{"title":"Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma \u2014 NEJM","url":"https:\/\/www.facebook.com\/205367482920841\/posts\/221240791333510","license":"public","citation_ids":[1871579],"posted_on":"2013-11-04T00:40:56+00:00","summary":"\u00bfCu\u00e1ndo ser\u00eda m\u00e1s efectivo realizar un trasplante aut\u00f3logo en un LNH? En un estudio publicado esta semana en el NEJM tratan de arrojar luz. \n\nhttp:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1301077?query=featured_home","author":{"name":"Servicio de Hematolog\u00eda Hospital Universitario 12 de Octubre","url":"https:\/\/www.facebook.com\/205367482920841","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/205367482920841\/picture","id_on_source":"205367482920841"}}],"news":[{"title":"New study evaluates early stem cell transplants for non-Hodgkin's lymphoma","url":"http:\/\/medicalxpress.com\/news\/2013-10-early-stem-cell-transplants-non-hodgkin.html","license":"public","citation_ids":[1871579],"posted_on":"2013-10-30T22:00:12+00:00","summary":"Performing early stem cell transplants in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published in the New England Journal of Medicine.","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"NEJM Study Evaluates Early Stem Cell Transplants for Non-Hodgkin's Lymphoma","url":"http:\/\/www.newswise.com\/articles\/nejm-study-evaluates-early-stem-cell-transplants-for-non-hodgkin-s-lymphoma","license":"public","citation_ids":[1871579],"posted_on":"2013-10-30T22:00:00+00:00","summary":"Early stem cell transplants for non-Hodgkin's lymphoma do not improve overall survival in high-risk patients. But early transplantation does appear to benefit very high-risk patients, according to a study in the New England Journal of Medicine.","author":{"name":"Newswise","url":"http:\/\/www.newswise.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/200\/normal\/image.png?1370251547"}},{"title":"Early stem cell transplants does not improve overall survival in non-Hodgkin's lymphoma patients","url":"http:\/\/www.news-medical.net\/news\/20131031\/Early-stem-cell-transplants-does-not-improve-overall-survival-in-non-Hodgkins-lymphoma-patients.aspx","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T06:18:47+00:00","summary":"Performing early stem cell transplants in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published in the New England Journal of Medicine.","author":{"name":"The Medical News","url":"http:\/\/www.news-medical.net\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/146\/normal\/image.png?1369927508"}},{"title":"Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients","url":"http:\/\/www.drugs.com\/news\/early-stem-cell-transplant-may-benefit-some-non-hodgkin-s-lymphoma-patients-48597.html","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T13:00:06+00:00","summary":"THURSDAY, Oct. 31 -- Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin's lymphoma, but may be beneficial for a small group of patients with the very highest risk, according to a new...","author":{"name":"Drugs.com","url":"http:\/\/www.drugs.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/406\/normal\/Screen_Shot_2016-02-03_at_10.28.55.png?1454495345"}},{"title":"Stem cell transplant not always effective","url":"http:\/\/www.health24.com\/Medical\/Cancer\/News\/Stem-cell-transplant-not-always-effective-20131101","license":"public","citation_ids":[1871579],"posted_on":"2013-11-01T11:10:12+00:00","summary":"Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin's lymphoma.","author":{"name":"Health24","url":"http:\/\/www.health24.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/460\/normal\/Screen_Shot_2016-02-03_at_09.57.37.png?1454493471"}},{"title":"Study evaluates early stem cell transplants for non-Hodgkin's lymphoma","url":"http:\/\/www.medicalnewstoday.com\/releases\/268214.php","license":"public","citation_ids":[1871579],"posted_on":"2013-11-04T08:00:00+00:00","summary":"Performing early stem cell transplants in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published in the New England Journal of Medicine. But early transplantation does appear","author":{"name":"Medical News Today","url":"http:\/\/www.medicalnewstoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/040\/normal\/medical_news_today.png?1369846932"}},{"title":"Autologous Transplantation as Consolidation Improves Progression-Free Survival in Aggressive Non-Hodgkin Lymphoma","url":"http:\/\/www.ascopost.com\/issues\/december-15,-2013\/autologous-transplantation-as-consolidation-improves-progression-free-survival-in-aggressive-non-hodgkin-lymphoma.aspx","license":"public","citation_ids":[1871579],"posted_on":"2013-12-11T00:00:00+00:00","summary":"The strategy of autologous stem-cell transplantation as consolidation in high-intermediate\u2013 or high-risk diffuse aggressive non-Hodgkin lymphoma (NHL) has not been specifically examined in the rituximab (Rituxan) era. In the phase III Southwest Oncology Gr","author":{"name":"The ASCO Post","url":"http:\/\/www.ascopost.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/496\/normal\/Screen_Shot_2016-02-03_at_09.24.05.png?1454491455"}},{"title":"Study evaluates early stem cell transplants for non-Hodgkin's lymphoma","url":"http:\/\/www.sciencedaily.com\/releases\/2013\/10\/131030185146.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29","license":"public","citation_ids":[1871579],"posted_on":"2013-10-30T22:51:51+00:00","summary":"Early stem cell transplants for non-Hodgkin\u2019s lymphoma do not improve overall survival in high-risk patients. But early transplantation does appear to benefit very high-risk patients.","author":{"name":"Science Daily","url":"http:\/\/www.sciencedaily.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/179\/normal\/image.png?1369927053"}},{"title":"Stem-Cell Therapy Misses Mark in Lymphoma Trial (CME\/CE)","url":"http:\/\/www.medpagetoday.com\/HematologyOncology\/Lymphoma\/42600","license":"public","citation_ids":[1871579],"posted_on":"2013-10-30T21:19:38+00:00","summary":"(MedPage Today) -- Progression of aggressive non-Hodgkin's lymphoma slowed significantly after autologous stem-cell transplantation, although overall survival did not improve, according to results of a randomized trial.","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}},{"title":"NEJM study evaluates early stem cell transplants for non-Hodgkin's lymphoma","url":"http:\/\/www.eurekalert.org\/pub_releases\/2013-10\/luhs-nse102513.php","license":"public","citation_ids":[1871579],"posted_on":"2013-10-30T04:00:00+00:00","summary":"( Loyola University Health System ) Performing early stem cell transplants in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published in the New England Journal of Medicine. Bu","author":{"name":"EurekAlert!","url":"http:\/\/www.eurekalert.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/077\/normal\/image.png?1369859505"}},{"title":"Early stem cell transplants evaluated for non-Hodgkin\u2019s lymphoma patients at high risk of early relapse","url":"http:\/\/www.healthcanal.com\/cancers\/44469-early-stem-cell-transplants-evaluated-for-non-hodgkin%C2%92s-lymphoma-patients-at-high-risk-of-early-relapse.html","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T20:48:00+00:00","summary":"Remissions last longer, but survival not affected","author":{"name":"Health Canal","url":"http:\/\/www.healthcanal.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/221\/normal\/image.png?1370446573"}},{"title":"Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients","url":"http:\/\/www.nlm.nih.gov\/medlineplus\/news\/fullstory_142086.html","license":"public","citation_ids":[1871579],"posted_on":"2013-10-31T13:00:00+00:00","summary":"Study found increased survival rate but only for those with highest-risk disease Source: HealthDay Related MedlinePlus Pages: Lymphoma , Stem Cells","author":{"name":"MedlinePlus","url":"https:\/\/medlineplus.gov\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/363\/normal\/Screen_Shot_2016-02-02_at_16.40.46.png?1454431260"}}],"blogs":[{"title":"A new study evaluates early autologous stem cell transplantation for aggressive non-hodgkin's lymphoma","url":"http:\/\/grey-horizon.blogspot.co.uk\/2013\/11\/a-new-study-evaluates-early-autologous.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed:+GreyHorizon+(Grey+Horizon)","citation_ids":[1871579],"posted_on":"2013-11-07T21:51:00+00:00","summary":"Performing early stem cell transplantation in patients with aggressive non-Hodgkin's lymphoma does not improve overall survival in high-risk patients, according to a study published on 31 October, 2013 in the New England Journal of Medicine. But early tran","author":{"name":"Grey Horizon","url":"http:\/\/grey-horizon.blogspot.com\/","description":"A Grey Literature Current Awareness Tool in Cancer Care"}}],"googleplus":[{"title":"Autologous transplantation as consolidation for aggressive non-hodgkin's lymphoma. For more information...","url":"https:\/\/plus.google.com\/104484290654217117636\/posts\/6bx6PuX9naK","citation_ids":[1871579],"posted_on":"2013-11-27T14:05:17+00:00","summary":"Autologous transplantation as consolidation for aggressive non-hodgkin's lymphoma. For more information... Autologous transplantation as consolidation for aggressive non-hodgkin&#39;s lymphoma. For more information, visit http:\/\/ow.ly\/qtxXk\ufeff MMS: Error htt","author":{"name":"Lymphoma Hub","url":"https:\/\/plus.google.com\/+Lymphomahub","image":"https:\/\/lh4.googleusercontent.com\/-SlgPP69chxQ\/AAAAAAAAAAI\/AAAAAAAAAO4\/atxbhhEd5FM\/photo.jpg?sz=50","id_on_source":"104484290654217117636"}},{"title":"Early vs delayed\/salvage asct for high risk NHL \"Autologous Transplantation as Consolidation for Aggressive...","url":"https:\/\/plus.google.com\/117375699581221180708\/posts\/RPFWQA67TkG","citation_ids":[1871579],"posted_on":"2013-10-31T23:24:14+00:00","summary":"Early vs delayed\/salvage asct for high risk NHL \"Autologous Transplantation as Consolidation for Aggressive... Early vs delayed\/salvage asct for high risk NHL&quot;Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin&#39;s Lymphoma \u2014 NEJM","author":{"name":"John Lucas","url":"https:\/\/plus.google.com\/+JohnLucasMS_MD","image":"https:\/\/lh5.googleusercontent.com\/-wJvJbtdFd8s\/AAAAAAAAAAI\/AAAAAAABDqg\/cD9vxfgDbL8\/photo.jpg?sz=50","id_on_source":"117375699581221180708"}}]}}